(Reuters) - By Himangshu Watts
MUMBAI, July 23 - Indian drug maker Dr. Reddy's Laboratories Ltd. on Monday missed expectations with a 30.5 percent rise in first quarter net profit, although demand for cheaper generic drugs was strong as countries look to cut healthcare costs.
Read more at Reuters.com Market News
MUMBAI, July 23 - Indian drug maker Dr. Reddy's Laboratories Ltd. on Monday missed expectations with a 30.5 percent rise in first quarter net profit, although demand for cheaper generic drugs was strong as countries look to cut healthcare costs.
Read more at Reuters.com Market News
No comments:
Post a Comment